Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L19 pseudogene 5 (RPL19P5) is a processed pseudogene that shares sequence homology with the functional ribosomal protein gene RPL19, which encodes a component of the large 60S ribosomal subunit. Pseudogenes like RPL19P5 arise from duplication or retrotransposition events but generally lack functionality due to genetic lesions or the absence of regulatory elements, preventing the expression of functional protein. RPL19P5 does not encode an active protein, has no documented biological activity, and is not involved in disease or therapy. Its existence is typical of ribosomal protein gene families, which often have multiple processed pseudogenes dispersed across the genome.[4][5][7]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L19 pseudogene 5 (RPL19P5).